Back to Search
Start Over
A phase 1 study of PF-05082566 (anti-4-1BB) in patients with advanced cancer
- Source :
- Journal of Clinical Oncology. 32:3007-3007
- Publication Year :
- 2014
- Publisher :
- American Society of Clinical Oncology (ASCO), 2014.
-
Abstract
- 3007 Background: 4-1BB agonists markedly enhance cytotoxic T-cell responses, resulting in anti-tumor activity in several models. PF-05082566 is a fully humanized IgG2 agonist monoclonal antibody ta...
Details
- ISSN :
- 15277755 and 0732183X
- Volume :
- 32
- Database :
- OpenAIRE
- Journal :
- Journal of Clinical Oncology
- Accession number :
- edsair.doi...........476846fdc2f6458b15f4f9e408e43ebf
- Full Text :
- https://doi.org/10.1200/jco.2014.32.15_suppl.3007